about
Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review.Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis.Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients.Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes StValidation of a Chinese version of the Quality of Well-Being Scale-Self-Administered (QWB-SA) in patients with epilepsy.Health-related quality of life in adults reporting arthritis: analysis from the National Health Measurement StudyThe cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic reviewModeling rheumatoid arthritis using different techniques - a review of model construction and results.SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.Psychometric properties of the German version of the MacNew heart disease health-related quality of life questionnaireThe relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis.Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes?Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain.Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients.The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohortThe comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritisQALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique.Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review.Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis.Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.How to select the right cost-effectiveness model? : A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis.2014 consensus statement from the first Economics of Physical Inactivity Consensus (EPIC) conference (Vancouver).Health economic modelling of treatment sequences for rheumatoid arthritis: a systematic review.Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis.Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis.Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?Mapping the disease-specific LupusQoL to the SF-6D.Perspective on cost-effective utilization of cardiac resynchronization therapy.Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis.The Use of Mapping to Estimate Health State Utility Values.Cost-effectiveness of powered mobility devices for elderly people with disability.Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?Comparing and transforming PROMIS utility values to the EQ-5D.Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis.
P2860
Q30248347-9881E997-4F5C-43EF-B482-C4799EBEC698Q33893290-FD1DA8AB-3210-437F-A152-1F702935F942Q34129848-ED95AEDC-259B-44FF-AE33-7FBCC5BC12ACQ34275175-CB6F46C9-5D83-47C8-887C-B2BA4669095EQ34359171-A56E057A-1DFF-4E3B-B43F-29746103A85AQ35165243-62DDFCCF-38C7-4E46-8C6D-4216E8A4934FQ35188042-813BA5F2-6828-4100-992B-15DE4BFDFEBDQ35851012-834B9AA2-A625-4274-BA90-A132BA2D0D06Q35867796-276302CC-B244-4EF7-9659-D5087A30A930Q36161449-7A188557-FC09-42F5-92F5-203925F1D70DQ36778529-6A963E79-7923-4FA9-99E0-E2EEAA204122Q36798538-908CE46C-8323-4E63-A409-9CB1F429FD40Q36901337-F7327F66-B49F-4E3F-99B4-B127F198CED9Q37042212-83966807-7853-44B3-8906-A1BF743227CFQ37112087-52C8CD2C-A181-4711-A73C-D1283134E132Q37265106-BDB70EED-798C-437A-BD6B-CCD245C7337AQ37387224-544C0F54-781B-4EC7-B4A1-F64ABF8E1738Q37764874-188E4269-DE1F-4966-B92B-BD8DF471B537Q37782588-CDEA1094-E440-4688-96EC-848AAF482EEFQ37848117-C2342BD4-3CF8-4BDB-BE0E-BD0F0EF37BDEQ38170177-0BECEF0A-3B7A-4ADF-A82F-9843F54E4F6BQ38171360-5F57E701-DBA2-49E8-BCD0-F7B17ED0109EQ38185992-15A451BF-FEAB-462B-8296-0F2230237CFBQ38214502-0681D94C-7A50-4F24-85BE-328B864F0DF5Q38245618-DEB2F366-8E5C-4E18-B869-45B9083939ABQ39388069-D2B1AA44-1661-4295-A85D-6ACFEC90C304Q39888684-B163C8EA-B45D-4996-A766-222D5022D73BQ41651775-B98A90E9-CFB8-4BBD-B474-7E729A017FA5Q41687005-126AFC02-1FD5-42DC-A68A-2A7AAC8D1E66Q45375991-5E4D8EF9-67D1-4753-9309-673078994E9FQ47375172-DF65BF9C-0B05-4BD0-AAA0-A1DDAE2897F7Q47755831-D15BBBCB-A841-4549-8E61-38F3C5C659AFQ48051447-079B65C8-A29E-4E62-81D9-F7985586EECEQ48315614-0B0CD845-08D5-43D8-BA0B-858AE1627672Q48372464-C7099FCC-C68A-4475-A214-DA6B5FB5AD7DQ48707771-B115324E-7B5A-468C-A3DB-2228BD01B301
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Not all "quality-adjusted life years" are equal.
@en
Not all "quality-adjusted life years" are equal.
@nl
type
label
Not all "quality-adjusted life years" are equal.
@en
Not all "quality-adjusted life years" are equal.
@nl
prefLabel
Not all "quality-adjusted life years" are equal.
@en
Not all "quality-adjusted life years" are equal.
@nl
P2093
P1476
Not all "quality-adjusted life years" are equal.
@en
P2093
Esdaile JM
Najafzadeh M
P304
P356
10.1016/J.JCLINEPI.2006.09.006
P577
2006-12-22T00:00:00Z